Modalities to assess myocardial viability in the modern cardiology era

Coronary Artery Disease

Volumn 17, Issue 6, 2006, Pages 567-576

  Hamdan, Ashraf ^a,b   Zafrir, Nili ^a,b   Sagie, Alexander ^a,b   Kornowski, Ran ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cardiac magnetic resonance; Echocardiography; Electromechanical mapping; Positron emission tomography; Single photon emission computed tomography

Indexed keywords

AMMONIA N 13; DOBUTAMINE; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITRIC ACID DERIVATIVE; RUBIDIUM 82; TECHNETIUM 99M; TETROFOSMIN TC 99M; THALLIUM 201; TRACER;

CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ELECTROMECHANICAL MAPPING; EXERCISE TEST; HEART CATHETER; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

CONTRAST MEDIA; CORONARY DISEASE; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; MAGNETIC RESONANCE IMAGING; ORGANOTECHNETIUM COMPOUNDS; PROGNOSIS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33747190630     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200609000-00011     Document Type: Review

References (77)

1. Massie BM, Ahah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventing strategies and comprehensive disease management. Am Heart J 1997; 133:703-712.
2. Salazar HP, Talano JV. Viable myocardium: how much is enough? Echocardiography 2005; 22:59-70.
3. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982; 66:1146-1149.
4. Elsasser A, Schlepper M, Klovekorn WP, Cai WJ, Zimmermann R, Muller KD, et al. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation 1997; 96:2920-2931.
5. Bonow RO. The hibernating myocardium: implications for management of congestive heart failure. Am J Cardiol 1995; 75:17A-25A.
6. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997; 30:1451-1460.
7. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995; 91:663-670.
8. Baer FM, Voth E, Schneider CA, Theissen P, Schicha H, Sechtem U. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease: a functional and morphological approach to the detection of residual myocardial viability. Circulation 1995; 91:1006-1015.
9. Keck A, Hertting K, Schwartz Y, Kitzing R, Weber M, Leisner B, et al. Electromechanical mapping for determination of myocardial contractility and viability. A comparison with echocardiography, myocardial single-photon emission computed tomography, and positron emission tomography. J Am Coll Cardiol 2002; 40:1067-1074.
10. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002; 39:1151-1158.
11. Mori T, Minamiji K, Kurogane H, Ogawa K, Yoshida Y. Rest injected thallium-201 imaging for assessing viability of severe asynergic regions. J Nucl Med 1991; 32:1718-1724.
12. Dilsizian V, Rocco TP, Freedman NMT, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990; 323:141-146.
13. Picano E, Bento de Sousa MJ, de Moura Duarte LF, Pingitore A, Sicari R. Detection of viable myocardium by dobutamine and dipyridamole stress echocardiography. Herz 1994; 19:204-209.
14. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death. Circulation 1998; 97:535-543.
15. Zafrir N, Leppo JA, Reinhardt CP, Dahlberg ST. Thallium reinjection versus standard stress/delay redistribution imaging for prediction of cardiac events. J Am Coll Cardiol 1998; 31:1280-1285.
16. Cuocolo A, Pace L, Ricciardelli B, Chiariello M, Trimarco B, Salvatore M. Identification of viable myocardium in patients with coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m methoxyisobutyl isonitrile. J Nucl Med 1992; 33:505-511.
17. Maurea S, Cuocolo A, Pace L, Nicolai E, Nappi A, Imbriaco M, et al. Rest injected thallium-201 redistribution and resting technetium-99m methoxyisobutylisonitrile uptake in coronary artery disease: relation to the severity or coronary artery stenosis. Eur J Nucl Med 1993; 20:502-510.
18. Udelson JE, Coleman PS, Metherall J, Pandian NG, Gomez AR, Griffith JL, et al. Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Circulation 1994; 89:2552-2561.
19. Kauffman GJ, Boyne TS, Watson DD, Smith WH, Beller GA. Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction. J Am Coll Cardiol 1996; 27:1592-1597.
20. Matsunari I, Fujino S, Taki J, Senma J, Aoyama T, Wakasugi T, et al. Myocardial viability assessment with technetium-99m-tetrofosmin and thallium-201 reinjection in coronary artery disease. J Nucl Med 1995; 36:1961-1967.
21. Maurea S, Cuocolo A, Soricelli A, Castelli L, Nappi A, Squame F, et al. Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease. J Nucl Med 1995; 36:1945-1952.
22. Sciagra R, Bisi G, Santoro GM, Agnolucci M, Zoccarato O, Fazzini PF. Influence of the assessment of defect severity and intravenous nitrate administration during tracer injection on the detection of viable hibernating myocardium with data-based quantitative technetium 99m-labelled sestamibi single photon emission computed tomography. J Nucl Cardiol 1996; 3:221-230.
23. Bisi G, Sciagra R, Santoro GM, Rossi V, Fazzini PF. Technetium-99m- sestamibi imaging with nitrate infusion to detect viable hibernating myocardium and predict postrevascularisation recovery. J Nucl Med 1995; 36:1994-2000.
24. Chua T, Kiat H, Germano G, Maurer G, van Train K, Friedman J, et al. Gated technetium-99m sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability: correlation with echocardiography and rest thallium-201 scintigraphy. J Am Coll Cardiol 1994; 23:1107-1114.
25. Anagnostopoulos C, Gunning MG, Pennell DJ, Laney R, Proukakis H, Underwood SR. Regional myocardial motion and thickening assessed at rest by ECG-gated 99mTc-MIBI emission tomography and by magnetic resonance imaging. Eur J Nucl Med 1996; 23:909-916.
26. Bavelaar-Croon CDL, Kayser HWM, Van der Wall EE, de Roos A, Dibbets-Schneider P, Pauwels EK, et al. Left ventricular function: correlation of quantitative gated SPECT and MR imaging over a wide range of values. Radiology 2000; 217:572-575.
27. Everaert H, Vanhove C, Franken PR. Low-dose dobutamine gated single-photon emission tomography: comparison with stress echocardiography. Eur J Nucl Med 2000; 27:413-418.
28. Matsuos S, Matsumoto T, Nakae I, Kohl T, Masuda D, Takada M, et al. Prognostic value of ECG-gated thallium-201 single-photon emission tomography in patients with coronary artery disease. Ann Nucl Med 2004; 18:617-622.
29. Taillefer R, DePuey EG, Udelson JE, Beller GA, Latour Y, Reeves F. Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol 1997; 29:69-77.
30. Slart RH, Bax JJ, van Veldhuisen DJ, van der Wall EE, Irwan R, Sluiter WJ, et al. Prediction of functional recovery after revascularization in patients with chronic ischaemic left ventricular dysfunction: head-to-head comparison between (99m)Tc-sestamibi/(18)F-FDG DISA SPECT and (13)N-ammonia/(18)F-FDG PET. Eur J Nucl Med Mol Imaging 2006 (in press).
31. Delbeke D, Videlefsky S, Patton JA, Campbell MG, Martin WH, Ohana I, et al. Rest myocardial perfusion/metabolism imaging using simultaneous dual-isotope acquisition SPECT with technetium-99m-MIBI/fluorine-18-FDG. J Nucl Med 1995; 36:2110-2119.
32. Sandler MP, Videlefsky S, Delbeke D, Patton JA, Meyerowitz C, Martin WH, Ohana I. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography. J Am Coll Cardiol 1995; 26:870-878.
33. 99mTc-tetrofosmin-FDG collimated SPECT. J Nucl Med 2000; 41:1318-1323.
34. 99mTc- sestamibi on dual-isotope simultaneous acquisition SPET compared with PET. Eur J Nucl Med Mol Imaging 2002; 29:1357-1364.
35. Slart RH, Bax JJ, de Boer J, Willemsen AT, Mook PH, Oudkerk M, et al. Comparison of 99mTc-sestamibi/18FDG DISA SPECT with PET for the detection of viability in patients with coronary artery disease and left ventricular dysfunction. Eur J Nucl Med Mol Imaging 2005; 32:972-979.
36. 201Tl uptake and comparative prediction of recovery of function. Circulation 1997; 95:626-635.
37. Bax JJ, Poldermans D, Elhendy A, Boersma E, Rahimtoola SH. Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol 2001; 26:141-186.
38. Pagano D, Bonser RS, Townend JN, Ordoubadi F, Lorenzoni R, Camici PG. Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischemic heart failure. Heart 1998; 79:281-288.
39. Galiuto L, Ignone G, De Maria AN. Contraction and relaxation of the normal left ventricle using pulsed wave tissue Doppler echocardiography. Am J Cardiol 1998; 81:609-614.
40. Hoffmann R, Altiok E, Nowak B, Heussen N, Kuhl H, Kaiser HJ, et al. Strain rate measurement by Doppler echocardiography allows improved assessment of myocardial viability inpatients with depressed left ventricular function. J Am Coll Cardiol 2002; 39:443-449.
41. Kaul S, Ito H. Microvasculature in acute myocardial ischemia. Part I: evolving concepts in pathophysiology, diagnosis, and treatment. Circulation 2004; 109:146-149.
42. Kaul S, Ito H. Microvasculature in acute myocardial ischemia. Part II: evolving concepts in pathophysiology, diagnosis, and treatment. Circulation 2004; 109:310-315.
43. Shimoni S, Frangogiannis NG, Aggeli CJ, Shan K, Verani MS, Quinones MA, et al. Identification of hibernating myocardium with quantitative intravenous myocardial contrast echocardiography: comparison with dobutamine echocardiography and thallium-201 scintigraphy. Circulation 2003; 107:538-544.
44. Zoghbi WA. Evaluation of myocardial viability with contrast echocardiography. Am J Cardiol 2002; 90 (Suppl 10A):65J-71J.
45. Senior R, Swinburn JM. Incremental value of myocardial contrast echocardiography for the prediction of recovery of function in dobutamine nonresponsive myocardium early after acute myocardial infarction. Am J Cardiol 2003; 91:397-402.
46. Ahmad M, Xie T, McCulloch M, Abreo G, Runge M. Real-time three-dimensional dobutamine stress echocardiography in assessment stress echocardiography in assessment of ischemia comparison with two-dimensional dobutamine stress echocardiography. J Am Coll Cardiol 2001; 37:1303-1309.
47. Shiota T, Jones M, Chikada M, Fleishman CE, Castellucci JB, Cotter B, et al. Real-time three-dimensional echocardiography for determining right ventricular stroke volume in an animal model of chronic right ventricular volume overload. Circulation 1998; 97:1897-1900.
48. Mondelli J, Di Luzio S, Nagaraj A, Kane BJ, Smulevitz B, Nagaraj AV, et al. The validation of volumetric real-time 3-dimensional echocardiography for the determination of left ventricular function. J Am Soc Echocardiogr 2001; 14:994-1000.
49. Gerber BL, Rochitte CE, Bluemke DA, Melin JA, Crosille P, Becker LC, et al. Relation between Gd-DTPA contrast enhancement and regional inotropic response in the periphery and center of myocardial infarction. Circulation 2001; 104:998-1004.
50. Hillenbrand HB, Kim RJ, Parker MA, Fieno DS, Judd RM. Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation 2000; 102:1678-1683.
51. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343:1445-1453.
52. Luechinger R, Zeijlemaker VA, Boesiger P, Duru F. Potential harmful effects of magnetic resonance imaging in pacemaker patients should not be underestimated. Eurospace 2006; 8:389-390.
53. Nagel E, Lehmkuhl HB, Bocksch W, Klein C, Vogel U, Frantz E, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 1999; 99:763-770.
54. Baer FM, Theissen P, Crnac J, Schmidt M, Deutsch HJ, Sechtem U, et al. Head to head comparison of dobutamine-transoesophageal echocardiography and dobutamine-magnetic resonance imaging for the prediction of left ventricular functional recovery in patients with chronic coronary artery disease. Eur Heart J 2000; 21:981-991.
55. Wu KC, Lima JA. Noninvasive imaging of myocardial viability. Current techniques and future developments. Circ Res 2003; 93:1146-1158.
56. Allard M, Doucet D, Kien P. Experimental study of DOTA-gadolinium. Pharmacokinetics and pharmacologic properties. Invest Radiol 1988; 23:S271-S274.
57. Mahnken AH, Koos R, Katoh M, Wildberger JE, Spuentrup E, Buecker A, et al. Assessment of myocardial viability in reperfused acute myocardial infarction using 16-slice computed tomography in comparison to magnetic resonance imaging. J Am Coll Cardiol 2005; 45:2042-2047.
58. Nikolaou K, Sanz J, Poon M, Wintersperger BJ, Ohnesorge B, Rius T, et al. Assessment of myocardial perfusion and viability from routine contrast-enhanced 16-detector-row computed tomography of the heart: preliminary results. Eur Radiol 2005; 15:864-871.
59. Knopp AF, Heuschmid M, Reimann A, Wintersperger BJ, Ohnesorge B, Rius T, et al. Evaluation of cardiac function and myocardial viability with 16-and 64-slice multidetector computed tomography. Eur Radiol 2005; 15:D15-D20.
60. Ben-Haim SA, Osadchy D, Schuster I, Gepstein L, Hayam G, Josephson ME, et al. Nonfluoroscopic, in vivo navigation and mapping technology. Nat Med 1996; 2:1393-1395.
61. Downar E, Janse MJ, Durrer D. The effect of acute coronary artery occlusion on subepicardial transmembrane potentials in the intact porcine heart. Circulation 1977; 56:217-224.
62. Franz MR, Flaherty JT, Platia EV, Bulkley BH, Weisfeldt ML. Localization of regional myocardial ischemia by recording of monophasic action potentials. Circulation 1984; 69:593-604.
63. Kornowski R, Hong MK, Gepstein L, Goldstein S, Ellahham S, Ben-Haim SA, et al. Preliminary animal and clinical experiences using an electromechanical endocardial mapping procedure to distinguish infarcted from healthy myocardium. Circulation 1998; 98:1116-1124.
64. Gepstein L, Goldin A, Lessick J, Hayam G, Shpan S, Schwartz Y, et al. Electromechanical characterization of chronic myocardial infarction in the canine coronary occlusion model. Circulation 1998; 98:2055-2064.
65. Callans DJ, Ren J-F, Michele J, Marchlinski FE, Dillon SM. Electroanatomical left ventricular mapping in the porcine model of healed anterior myocardial infarction. Correlation with intracardiac echocardiography and pathological analysis. Circulation 1999; 100:1744-1750.
66. Kornowski R, Hong MK, Leon MB. Comparison between left ventricular electromechanical mapping and radionuclide perfusion imaging for detection of myocardial viability. Circulation 1998; 98:1837-1841.
67. Fuchs S, Kornowski R, Shiran A, Pierre A, Ellahham S, Leon MB. Electromechanical characterization of myocardial hibernation in a pig model. Coron Artery Dis 1999; 10:195-198.
68. Wiggers H, Botker HE, Sogaard P, Kaltoft A, Hermansen F, Kim WY, et al. Electromechanical mapping versus positron emission tomography and single-photon emission computed tomography for the detection of myocardial viability in patients with ischemic cardiomyopathy. J Am Coll Cardiol 2003; 41:843-848.
69. Silva GV, Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, et al. Catheter-based transendocardial delivery of autologous bone-marrow-derived mononuclear cells in patients listed for heart transplantation. Tex Heart Inst J 2004; 31:214-219.
70. Kornowski R, Leon MB, Fuchs S, Vodovotz Y, Flynn MA, Gordon DA, et al. Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy. Results in normal and ischemic porcine models. J Am Coll Cardiol 2000; 35:1031-1039.
71. Botker HE, Lassen JF, Hermansen F, Wiggers H, Sogaard P, Kim WY, et al. Electromechanical mapping for detection of myocardial viability in patients with ischemic cardiomyopathy. Circulation 2001; 103:1631-1637.
72. Masood Y, Liu YH, Depuey G, Taillefer R, Araujo LI, Allen S, et al. Clinical validation of SPECT attenuation correction using X-ray computed tomography-derived attenuation maps: multicenter clinical trial with angiographic correlation. J Nucl Cardiol 2005; 12:676-686.
73. Rimoldi O, Schafers KP, Boellaard R, Turkheimer F, Stegger L, Law MP, et al. Quantification of subendocardial and subepicardial blood flow using 15O-labeled water and PET: experimental validation. J Nucl Med 2006; 47:163-172.
74. Willemsen AT, Siebelink HJ, Blanksma PK, Paans AM. Automated ejection fraction determination from gated myocardial FDG-PET data. J Nucl Cardiol 1999; 6:577-582.
75. Stuber M, Botnar RM, Fischer SE, Lamerichs R, Smink J, Harvey P, Manning WJ. Preliminary report on in vivo coronary MRA at 3 Tesla in humans. Magn Reson Med 2002; 48:425-429.
76. Kraitchman DL, Sampath S, Castillo E, Derbyshire JA, Boston RC, Bluemke DA, et al. Quantitative ischemia detection during cardiac magnetic resonance stress testing by use of FastHARP. Circulation 2003; 107:2025-2030.
77. Osman NF, Sampath S, Atalar E, Prince JL. Imaging longitudinal cardiac strain on short-axis images using strain-encoded MRI. Magn Reson Med 2001; 46:324-334.